XML 22 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Statements of Cash Flows (USD $)
 3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Cash flows from operating activities    
Net loss $ (82,516) $ (83,157)
Change in operating assets and liabilities:    
Accounts payable & accrued expenses (191,064) 55,984
Prepaid assets (94,250) (94,250)
Net cash used in operating activities (367,830) (121,423)
Cash flows from investing activities    
Investment in restricted cash and investments (46,003,198) (46,003,198)
Net cash used in investing activities (46,003,198) (46,003,198)
Cash flows from financing activities    
Proceeds from sale of shares of common stock to initial stockholder 0 25,000
Proceeds from note payable - stockholder 0 125,000
Proceeds from sale of units in IPO, including over-allotment, net of offering costs 44,168,216 44,168,216
Proceeds from private placement of units, including over-allotment 1,980,000 1,980,000
Proceeds from private placement of $15 exercise price warrants 300,000 300,000
Proceeds from sale of underwritter purchase option 100 100
Deferred costs associated with initial public offering 306,798 0
Net cash provided by financing activities 46,755,114 46,598,316
Net increase in cash 384,086 473,695
Cash at beginning of period 89,609 0
Cash at end of period 473,695 473,695
Supplemental disclosure for non-cash financing activities    
Accrual of deferred offering cost $ 306,798 $ 0